Chronic kidney disease stage 3-5 combined with hypertension
Conditions
Interventions
Non-dialysis chronic kidney disease stage 3-5 combined with hypertension treated with sacubitril valsartan:NA
Sponsors
Affiliated Zhongda Hospital of Southeast University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1: Meets diagnostic criteria for CKD stages 3-5 2: 18 years = age = 85 years 3: Systolic blood pressure = 140 mmHg and/or diastolic blood pressure = 90 mmHg 4: Oral treatment with sacubitril valsartan and use for =1 month
Exclusion criteria
Exclusion criteria: 1: Currently on renal replacement therapy 2: Severe hepatic impairment, biliary cirrhosis and cholestasis 3: Combined use of RAAS inhibitors 4: Lack of relevant pre- or post-dose laboratory findings
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood pressure; | — |
Countries
China
Contacts
Public ContactBing Wang
Affiliated Zhongda Hospital of Southeast University
Outcome results
None listed